Maria João Sousa|Cecília Caramujo|Núñez Julio|Joana Magalhães|Raquel Basto|Teresa Fraga|Inês Gomes|Isabel Pazos|Gabriela Sousa
1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil|Instituto Português de Oncologia de Coimbra Francisco Gentil
april 2021 declared 140 million cases 3 million deaths due covid19 effectively control pandemic significant part population acquire immunity best achieved vaccination none clinical trials evaluating effectiveness safety vaccines included cancer patients study aimed evaluate acceptance covid19 vaccine cancer patients undergoing immunosuppressive therapy portuguese cancer centre unicentric crosssectional survey conducted cancer patients solid malignancy chemotherapy targeted agents immunotherapy march april 2021 included 169 patients 109 female 60 male median age 61 years old 2982 half n105 621 lower literacy degree 97 574 lived countryside majority patients receiving palliative treatment n87 515 patients intended vaccinated n142 840 24 142 unsure 3 18 negative answers given patients receiving palliative treatment logistic regression analysis revealed high school qualification p0007 divorced status p 0037 rural residence p0047 believing vaccine p0001 statistically significant effect probability patients wanting vaccinated frequent reasons wanting vaccinated sense collective responsibility fear severe disease frequent reasons wanting vaccinated lack evidence wish wait end treatment need information effectiveness safety main reasons uncertainty related vaccine despite lack information regarding efficacy duration immunity timing vaccination cancer patients immunosuppressive therapy study demonstrated majority patients intend vaccinated covid19 results related residence type literacy belief effectiveness vaccine higher acceptance rate study compared studies must noted